Older HIV patients with metabolic comorbidities who transition to a single-tablet BIC/LEN experience low rates of severe adverse events and treatment discontinuations.

The new RFD4-Proteina unified generative model for protein design—created by the Institute for Protein Design (IPD) in ...

HIV isn’t taking a holiday in Neno, where more than 409 new cases were registered in the first nine months of 2026, raising ...

South Africa's rollout of lenacapavir, a six-monthly HIV prevention injection, requires nurses to learn, adapt and find ways to make it work for patients.

South Africa’s rollout of lenacapavir, a six-monthly HIV prevention injection, requires nurses to learn, adapt and find ways ...

Manchester scientists test AI-designed enzymes for key step in lenacapavir synthesis, showing how protein design could ...

Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

South Africa has 8 million people living with HIV, and the government has introduced lenacapavir, a new HIV prevention drug.

The MCAZ has also demonstrated its capacity to expedite regulatory processes, with Mr Kaiyo citing the registration of ...

Czech Foreign Minister Petr Macinka on Thursday presented the Gratias Agit Awards honouring individuals and organisations for promoting the Czech Republic abroad. The 13 laureates include Czech-born ...

Among the 100 recipients, median time from prescription to first injection was 12 days (interquartile range [IQR], 6-23). In ...

AVAC and Access Bridge today issued a global call to action urging governments, donors, manufacturers, implementers, and advocates to work toward a bold but achievable goal: reaching at least three ...